University of Alberta
114 Street - 89 Avenue
99 articles about University of Alberta
Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology
Tonix Pharmaceuticals Holding Corp. announced that Tom Hobman, Ph.D., Professor, Department of Cell Biology, University of Alberta, presented data from his laboratory at The University of Alberta as a keynote presentation at the 4th Symposium of the Canadian Society for Virology held in Edmonton, Alberta, Canada on June 5, 2022.
CRISPR Therapeutics reported in its first-quarter financials, as of March 31, it had $2.221 billion in cash, cash equivalents and marketable securities to drive its progress.
The Diabetes Research Institute Foundation Joins Forces with Their Canadian Counterpart to Form Powerhouse Partnership to Fund the Search for a Diabetes Cure
The Diabetes Research Institute along with the Diabetes Research Institute Foundation Canada and Alberta Diabetes Institute at the University of Alberta, Canada's largest stand-alone research facility dedicated to finding a cure of diabetes, announced the launch of a research partnership to advance efforts to find a cure for diabetes.
Mount Sinai researchers have discovered a key mechanism for how this occurs in breast cancer. For that and more research stories, continue reading.
Tonix Pharmaceuticals Enters into Research Collaboration and Exclusive License Agreement with University of Alberta to Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 and TNX-1830, for the Prevention of COVID-19
TNX-1810, TNX-1820 and TNX-1830 are Designed to Express Protein Antigens from SARS-CoV-2 That are Different from TNX-1800, Which is Designed to Express Spike Protein
ACAMP Working with University of Alberta has Developed a Washable Cloth Based Filter and Plastic Respirator With Over 95% Filtration Efficiency
PPE A95 Canadian respirator to help prevent the spread of COVID-19
Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids
Successful impregnation of gum arabic-CoQ10 bolsters Ceapro’s efforts to develop innovative delivery systems composed of new chemical complexes
Researchers with the University of Alberta recently identified a unique biological marker for myasthenia gravis that might be used for a diagnostic test and to predict the course of the disease. It may also have implications for defining more personalized treatments.
September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...
9/21/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
IBM And University of Alberta Publish New Data On Machine Learning Algorithms To Help Predict Schizophrenia
New Blood Test Identifies Women At Risk Of Preterm Delivery As Early As 17 Weeks Of Pregnancy, University of Alberta Study
RespireRx , University of Alberta And University of Florida Provide Update On Collaborative Research Activities
Zika Virus Researchers Join Forces To Develop Handheld Detection Device, University of Alberta Study
ProtoKinetix Inc. Reports On Its Strong Collaboration With The James Shapiro Laboratory At The University of Alberta
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Second Clinical Trial Site At University of Alberta
NightstaRx And University of Alberta Announce The Start Of The First Canadian Gene Therapy Study To Treat Choroideremia